Pharma Business - May 5, 2015
Novo Opening New Facility
Novo Nordisk broke ground May 4 on a new 7,500 m2 manufacturing facility in Kalundborg, Denmark. The company is investing 1.5 billion Danish kroner in the facility, which will produce active pharmaceutical ingredients for NovoSeven®and future products for treating hemophilia. The investment is estimated to create 100 new production and engineering jobs in Kalundborg, where […]
Pharma Business - April 17, 2015
Novo Opens Russian Facility
Novo Nordisk has opened a new manufacturing facility in the Kaluga region of Russia for the production of modern devices for administering insulin for treating diabetes. The facility will produce both Penfill® cartridges and FlexPen® prefilled insulin injection pens for the Russian market, according to FiercePharma. The new facility is located in Technopark Grabtsevo and […]